Rankings
▼
Calendar
KMDA Q2 2021 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q2 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$24M
-26.7% YoY
Gross Profit
$9M
37.4% margin
Operating Income
$1M
4.3% margin
Net Income
$937,000
3.9% margin
EPS (Diluted)
$0.02
QoQ Revenue Growth
-2.7%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$5M
Stock-Based Comp.
$155,000
Balance Sheet
Total Assets
$216M
Total Liabilities
$34M
Stockholders' Equity
$182M
Cash & Equivalents
$68M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$33M
-26.7%
Gross Profit
$9M
$11M
-18.4%
Operating Income
$1M
$4M
-73.7%
Net Income
$937,000
$3M
-72.9%
← FY 2021
All Quarters
Q3 2021 →